rethinkPeptides Search
Menu
Study breakdown

CGRP Levels Are Over Twice as High in Rheumatoid Arthritis Patients and Correlate with Disease Activity

evidence
The takeaway

Serum CGRP levels were significantly elevated in RA patients (91.1 vs 40.8 pg/mL) and correlated with disease activity scores, suggesting CGRP as both a biomarker and potential therapeutic target.

91.1 vs 40.8 pg/mL

RA patients had over twice the serum CGRP levels of healthy controls, with even higher levels in seropositive disease

What the researchers found

Serum CGRP was significantly elevated in RA (91.1 vs 40.8 pg/mL, p<0.001), with seropositive patients showing higher levels (118.7 pg/mL). CGRP correlated with DAS-28, HAQ, and VAS scores and was an independent predictor of active disease.

Why it matters

CGRP is already targeted by migraine drugs (anti-CGRP antibodies). Finding it elevated in RA opens the question of whether these same drugs could help manage rheumatoid arthritis pain and inflammation.

How the study worked

Cross-sectional case-control study with 80 RA patients and 40 healthy controls, using ELISA for CGRP measurement, ROC analysis for diagnostic cutoffs, and logistic regression for predictor analysis.

What this study cannot tell us

Cross-sectional design cannot establish causation. Moderate sample size. Cannot determine if elevated CGRP drives disease or results from it. Single-center study.

How to read the evidence

Well-designed case-control study with appropriate statistical analysis. Moderate sample size with clear findings, but cross-sectional design limits causal inference.

When this study was published

Published in 2026, representing emerging research on CGRP's role beyond migraine.

The bigger picture

If CGRP contributes to RA pathophysiology (not just pain), anti-CGRP therapies already on the market for migraines could potentially be repurposed for RA, representing a new therapeutic avenue.

Questions still open

  • Could anti-CGRP antibodies (erenumab, fremanezumab) reduce RA disease activity?
  • Does CGRP elevation precede RA flares and serve as an early warning biomarker?
  • Is CGRP driving joint inflammation or primarily mediating RA-associated pain?

Common questions

What is CGRP and why does it matter in arthritis?
CGRP (calcitonin gene-related peptide) is a neuropeptide involved in pain and inflammation. This study found it is significantly elevated in rheumatoid arthritis and correlates with how active the disease is, suggesting it plays a role in RA.
Could migraine drugs help with rheumatoid arthritis?
It is an interesting possibility. Anti-CGRP drugs used for migraines target the same molecule found elevated in RA. However, clinical trials would be needed to test whether they actually help with arthritis.

Read the original research

A Cross-Sectional Study on Elevated Serum Calcitonin Gene-Related Peptide Levels in Rheumatoid Arthritis Patients and Their Relationship with Disease Activity.

Archives of rheumatology, 41(1), 29-39

Citation

Dede Akpınar, Merve; Ataoğlu, Safinaz; Cangür, Şengül. (2026). A Cross-Sectional Study on Elevated Serum Calcitonin Gene-Related Peptide Levels in Rheumatoid Arthritis Patients and Their Relationship with Disease Activity.. Archives of rheumatology, 41(1), 29-39. https://doi.org/10.5152/ArchRheumatol.2026.10704